COMMONWEALTH BIOTECHNOLOGIES INC (CBTE) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 38 transactions totaling $3.3M, demonstrating a bearish sentiment with -$3.3M in net insider flow. The most recent transaction on Jan 19, 2010 involved a sale of 19,100 shares valued at $9.6K.
No significant insider buying has been recorded for CBTE in the recent period.
No significant insider selling has been recorded for CBTE in the recent period.
Based on recent SEC filings, insider sentiment for CBTE is bearish with an Insider Alignment Score of 1/100 and a net flow of -$3.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at COMMONWEALTH BIOTECHNOLOGIES INC (CBTE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading CBTE stock, having executed 38 transactions in the past 90 days. The most active insider is Chemistry Ltd. Pharmaust (Executive), who has made 1 transactions totaling $3.1M.
Get notified when executives and directors at CBTE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 19, 2010 | D'sylva Paul | Executive | Sale | 19,100 | $0.50 | $9.6K | |
| May 29, 2009 | D'sylva Paul | Executive | Purchase | 12,000 | $0.40 | $4.8K | |
| May 15, 2009 | D'sylva Paul | Executive | Purchase | 510 | $0.38 | $194 | |
| May 14, 2009 | D'sylva Paul | Executive | Purchase | 2,800 | $0.40 | $1.1K | |
| May 5, 2009 | D'sylva Paul | Executive | Purchase | 23,934 | $0.35 | $8.4K | |
| May 4, 2009 | D'sylva Paul | Executive | Purchase | 500 | $0.35 | $175 | |
| May 1, 2009 | D'sylva Paul | Executive | Purchase | 5,866 | $0.35 | $2.1K | |
| Apr 30, 2009 | D'sylva Paul | Executive | Purchase | 19,706 | $0.35 | $6.9K | |
| Dec 29, 2008 | H. Brennan James | Executive | Award | 25,000 | $N/A | $0 | |
| Dec 29, 2008 | J. Freer Richard | Executive | Award | 25,000 | $N/A | $0 | |
| Dec 29, 2008 | B. Harris Robert | Executive | Award | 25,000 | $N/A | $0 | |
| Dec 29, 2008 | R. Reynolds Thomas | Executive | Award | 25,000 | $N/A | $0 | |
| Sep 25, 2008 | J. Freer Richard | Executive | Purchase | 5,000 | $0.98 | $4.9K | |
| Sep 12, 2008 | Ltd. Pharmaust Chemistry | Executive | Sale | 2,150,000 | $1.45 | $3.1M | Large |
| May 27, 2008 | B. Harris Robert | Executive | Sale | 10,000 | $1.59 | $15.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 14 | $3.3M | 98.4% |
Purchase(P) | 11 | $40.2K | 1.2% |
Exercise(M) | 1 | $15.0K | 0.4% |
Award(A) | 12 | $0 | 0.0% |
Insider selling pressure at COMMONWEALTH BIOTECHNOLOGIES INC has increased, with 8 insiders executing 38 transactions across all time. Total sales of $3.3M significantly outpace purchases of $40.2K, resulting in a net outflow of $3.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.